• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于远程地区的移动健康数据采集系统,以监测参与宫颈癌筛查活动的妇女。

A Mobile Health Data Collection System for Remote Areas to Monitor Women Participating in a Cervical Cancer Screening Campaign.

机构信息

1 Faculty of Medicine, University of Geneva , Geneva, Switzerland .

2 Gynecology Division, Geneva University Hospitals , Geneva, Switzerland .

出版信息

Telemed J E Health. 2018 Apr;24(4):277-282. doi: 10.1089/tmj.2017.0146. Epub 2017 Aug 28.

DOI:10.1089/tmj.2017.0146
PMID:28846504
Abstract

BACKGROUND

Barriers to efficient cervical cancer screening in low- and medium-income countries include the lack of systematic monitoring of the participants' data. The aim of this study was to assess the feasibility of a mobile health (m-Health) data collection system to facilitate monitoring of women participating to cervical cancer screening campaign.

METHODS

Women aged 30-65 years, participating in a cervical cancer screening campaign in Ambanja, Madagascar, were invited to participate in the study. Cervical Cancer Prevention System, an m-Health application, allows the registration of clinical data, while women are undergoing cervical cancer screening. All data registered in the smartphone were transmitted onto a secure, Web-based platform through the use of an Internet connection. Healthcare providers had access to the central database and could use it for the follow-up visits. Quality of data was assessed by computing the percentage of key data missing.

RESULTS

A total of 151 women were recruited in the study. Mean age of participants was 41.8 years. The percentage of missing data for the key variables was less than 0.02%, corresponding to one woman's medical history data, which was not sent to the central database. Technical problems, including transmission of photos, human papillomavirus test results, and pelvic examination data, have subsequently been solved through a system update.

CONCLUSION

The quality of the data was satisfactory and allowed monitoring of cervical cancer screening data of participants. Larger studies evaluating the efficacy of the system for the women's follow-up are needed in order to confirm its efficiency on a long-term scale.

摘要

背景

在中低收入国家,宫颈癌筛查效率低下的障碍包括缺乏对参与者数据的系统监测。本研究旨在评估移动医疗(mHealth)数据收集系统在促进宫颈癌筛查活动中监测女性参与者的可行性。

方法

邀请年龄在 30-65 岁之间的参加马达加斯加安班扎宫颈癌筛查活动的女性参加这项研究。Cervical Cancer Prevention System 是一种 mHealth 应用程序,可在女性进行宫颈癌筛查时记录临床数据。智能手机中注册的所有数据都通过使用互联网连接传输到安全的基于 Web 的平台上。医疗保健提供者可以访问中央数据库,并在后续访问中使用它。通过计算关键数据缺失的百分比来评估数据质量。

结果

共有 151 名女性参加了这项研究。参与者的平均年龄为 41.8 岁。关键变量的缺失数据百分比小于 0.02%,对应于一名女性的病史数据,这些数据未发送到中央数据库。随后通过系统更新解决了包括传输照片、人乳头瘤病毒检测结果和盆腔检查数据在内的技术问题。

结论

数据质量令人满意,允许监测参与者的宫颈癌筛查数据。需要进行更大规模的研究来评估该系统对女性随访的效果,以确认其在长期范围内的效率。

相似文献

1
A Mobile Health Data Collection System for Remote Areas to Monitor Women Participating in a Cervical Cancer Screening Campaign.用于远程地区的移动健康数据采集系统,以监测参与宫颈癌筛查活动的妇女。
Telemed J E Health. 2018 Apr;24(4):277-282. doi: 10.1089/tmj.2017.0146. Epub 2017 Aug 28.
2
Text messages to increase attendance to follow-up cervical cancer screening appointments among HPV-positive Tanzanian women (Connected2Care): study protocol for a randomised controlled trial.通过短信提高坦桑尼亚HPV阳性女性宫颈癌筛查后续预约的出勤率(Connected2Care):一项随机对照试验的研究方案
Trials. 2017 Nov 21;18(1):555. doi: 10.1186/s13063-017-2215-x.
3
Muslim immigrant women's views on cervical cancer screening and HPV self-sampling in Ontario, Canada.加拿大安大略省穆斯林移民女性对宫颈癌筛查和人乳头瘤病毒自我采样的看法。
BMC Public Health. 2016 Aug 24;16(1):868. doi: 10.1186/s12889-016-3564-1.
4
Use of Smartphones as Adjuvant Tools for Cervical Cancer Screening in Low-Resource Settings.在资源匮乏地区使用智能手机作为宫颈癌筛查的辅助工具。
J Low Genit Tract Dis. 2015 Oct;19(4):295-300. doi: 10.1097/LGT.0000000000000136.
5
A tailored within-community specimen collection strategy increased uptake of cervical cancer screening in a cross-sectional study in Ghana.在加纳开展的一项横断面研究中,一种量身定制的社区内样本采集策略提高了宫颈癌筛查的参与率。
BMC Public Health. 2017 Aug 1;18(1):80. doi: 10.1186/s12889-017-4631-y.
6
Uptake of community-based, self-collected HPV testing vs. visual inspection with acetic acid for cervical cancer screening in Kampala, Uganda: preliminary results of a randomised controlled trial.乌干达坎帕拉基于社区的自我采集人乳头瘤病毒检测与醋酸目视检查用于宫颈癌筛查的比较:一项随机对照试验的初步结果
Trop Med Int Health. 2015 Oct;20(10):1355-67. doi: 10.1111/tmi.12549. Epub 2015 Jun 28.
7
Barriers to HPV self-sampling and cytology among low-income indigenous women in rural areas of a middle-income setting: a qualitative study.中低收入环境下农村地区低收入土著妇女 HPV 自我采样和细胞学检测障碍:定性研究。
BMC Cancer. 2017 Nov 9;17(1):734. doi: 10.1186/s12885-017-3723-5.
8
Self-collection based HPV testing for cervical cancer screening among women living with HIV in Uganda: a descriptive analysis of knowledge, intentions to screen and factors associated with HPV positivity.乌干达HIV感染者中基于自我采样的HPV检测用于宫颈癌筛查:对知识、筛查意愿及HPV阳性相关因素的描述性分析
BMC Womens Health. 2017 Jan 13;17(1):4. doi: 10.1186/s12905-016-0360-0.
9
Underutilization of cervical cancer prevention services in low and middle income countries: a review of contributing factors.低收入和中等收入国家宫颈癌预防服务利用不足:影响因素综述
Pan Afr Med J. 2015 Jul 30;21:231. doi: 10.11604/pamj.2015.21.231.6350. eCollection 2015.
10
Development of mobile technologies for the prevention of cervical cancer in Santiago, Chile study protocol: a randomized controlled trial.智利圣地亚哥预防宫颈癌移动技术的开发研究方案:一项随机对照试验
BMC Cancer. 2017 Dec 13;17(1):847. doi: 10.1186/s12885-017-3870-8.

引用本文的文献

1
The effectiveness of mobile health intervention in colorectal cancer screening in Iran.移动健康干预在伊朗结直肠癌筛查中的有效性。
J Res Med Sci. 2025 May 26;30:29. doi: 10.4103/jrms.jrms_21_25. eCollection 2025.
2
Bridging the gap in cervical cancer screening for underserved communities: MCED and the promise of future technologies.弥合服务不足社区宫颈癌筛查的差距:分子癌症早检及未来技术的前景
Front Oncol. 2024 Jul 29;14:1407008. doi: 10.3389/fonc.2024.1407008. eCollection 2024.
3
Mobile-Based Application Interventions to Enhance Cancer Control and Care in Low- and Middle-Income Countries: A Systematic Review.
基于移动设备的应用干预措施在中低收入国家增强癌症防控和照护的系统评价
Int J Public Health. 2023 Dec 5;68:1606413. doi: 10.3389/ijph.2023.1606413. eCollection 2023.
4
Digital health interventions for cervical cancer care: A systematic review and future research opportunities.数字健康干预在宫颈癌照护中的应用:系统综述及未来研究机遇。
PLoS One. 2023 Dec 15;18(12):e0296015. doi: 10.1371/journal.pone.0296015. eCollection 2023.
5
Implementing Smartphone-Based Telemedicine for Cervical Cancer Screening in Uganda: Qualitative Study of Stakeholders' Perceptions.在乌干达实施基于智能手机的宫颈癌筛查远程医疗:利益攸关方认知的定性研究。
J Med Internet Res. 2023 Oct 2;25:e45132. doi: 10.2196/45132.
6
Exploring usability problems of mHealth applications developed for cervical cancer: An empirical study.探索为宫颈癌开发的移动健康应用程序的可用性问题:一项实证研究。
SAGE Open Med. 2023 Jun 29;11:20503121231180413. doi: 10.1177/20503121231180413. eCollection 2023.
7
Innovations in healthcare delivery: Human papilloma virus self sampling diagnostics and participatory innovations for CCS.医疗保健服务创新:人乳头瘤病毒自我采样诊断和 CCS 的参与式创新。
Cancer Med. 2023 Jul;12(14):15544-15551. doi: 10.1002/cam4.6201. Epub 2023 Jun 16.
8
Digital cervicography for cervical cancer screening in low-resource settings: A scoping review.资源匮乏地区宫颈癌筛查的数字宫颈摄影术:一项范围综述。
Gynecol Oncol Rep. 2023 Jan 4;45:101130. doi: 10.1016/j.gore.2022.101130. eCollection 2023 Feb.
9
Inter- and intra-observer agreement in the assessment of the cervical transformation zone (TZ) by visual inspection with acetic acid (VIA) and its implications for a screen and treat approach: a reliability study.阴道镜下醋酸肉眼观察(VIA)评估宫颈转化区(TZ)的观察者间和观察者内一致性及其对筛查和治疗方法的影响:一项可靠性研究。
BMC Womens Health. 2023 Jan 19;23(1):27. doi: 10.1186/s12905-022-02131-z.
10
Evaluation of Usability and User Experience of Oncodoc 's M-Health Application for Early Detection of Cancer.评估 Oncodoc 的移动医疗应用程序在癌症早期检测中的可用性和用户体验。
Asian Pac J Cancer Prev. 2022 Dec 1;23(12):4169-4176. doi: 10.31557/APJCP.2022.23.12.4169.